One setback of early insulin therapy, however, is that it is associated with hyperphagia, weight gain and lipogenesis [194,195], which could exacerbate the insulin resistance and the metabolic alterations observed in T2D and lead to intensified treatment. Here, INS is linked to type 2 diabetes mellitus.